Myelodysplastic/Myeloproliferative Neoplasm

general

A category of clonal hematopoietic disorders that have both myelodysplastic and myeloproliferative features at the time of initial presentation.

37

Centers

40

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Myelodysplastic/Myeloproliferative Neoplasm(37)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.6
2
High-Volume Research Center
72.6
3
NCI Comprehensive
Active Research Program
65.9
4
NCI Comprehensive
Active Research Program
65.9
5
NCI Comprehensive
Active Research Program
65.9
6
NCI Comprehensive
Active Research Program
65.9
7
NCI Comprehensive
Active Research Program
65.9
8
NCI Comprehensive
Active Research Program
65.9
9
Active Research Program
65.9
10
Active Research Program
65.9
11
Active Research Program
65.9
12
NCI Comprehensive
Active Research Program
50.7
13
NCI Comprehensive
Active Research Program
50.7
14
NCI Comprehensive
Active Research Program
50.7
15
NCI Comprehensive
Active Research Program
50.7
16
NCI Comprehensive
Active Research Program
50.7
17
NCI Comprehensive
Active Research Program
50.7
18
NCI Comprehensive
Active Research Program
50.7
19
NCI Comprehensive
Active Research Program
50.7
20
NCI Clinical
Active Research Program
50.7
21
Active Research Program
50.7
22
NCI Clinical
Active Research Program
50.7
23
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.7
24
Active Research Program
50.7
25
Active Research Program
50.7
26
Active Research Program
50.7
27
Active Research Program
50.7
28
NCI Comprehensive
34.9
29
NCI Comprehensive
34.9
30
NCI Comprehensive
34.9
3134.9
32
NCI Comprehensive
34.9
33
NCI Comprehensive
34.9
3434.9
3534.9
3634.9
37
BC CancerVancouver, BC
34.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →